Global Prevalence of Cognitive Frailty in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.

Asia Pac PsychiatrySep 1, 2026
Clinical ResearchGeriatricsOpen access

Yi-Ran Huang, Shu-Ying Rao, Hui Li et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis assessed the global prevalence of cognitive frailty in community-dwelling older adults, analyzing 66 studies with 127,556 participants. The overall prevalence was found to be 12.2% (95% CI: 9.4%-15.7%). The study highlights the importance of identifying cognitive frailty due to its association with disability and dementia risk.

Key findings

  • The pooled prevalence of cognitive frailty was 12.2% (95% CI: 9.4%-15.7%).
  • Higher prevalence was noted in studies using the FRAIL scale or Fried phenotype.
  • Cognitive frailty prevalence was associated with alcohol use status in meta-regression analyses.
  • Publication bias may have led to an underestimation of cognitive frailty prevalence.

Why it matters

Cognitive frailty is a significant concern in aging populations, as it indicates a higher risk for disability and dementia. Understanding its prevalence can guide healthcare strategies for early identification and intervention.

Source

PubMed · PMID 42610492Free full text on PubMed Central

Published in Asia Pac Psychiatry. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Geriatrics

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.